SCHEMBL18514535

SCHEMBL18514535

CCc1ccc(OCc2c(NC(=O)OC)cccc2C(F)F)c(C(F)F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 5/20 0.36
KMT2A Q03164 4/20 0.36
HTT P42858 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.35
SLC22A12 Q96S37 1/20 0.34
MEN1 O00255 3/20 0.34
TSHR P16473 1/20 0.34
ALDH1A1 P00352 3/20 0.34
TDP1 Q9NUW8 1/20 0.34
PLAU P00749 1/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
POLB P06746 1/20 0.34
KDM4E B2RXH2 2/20 0.33
MAPT P10636 1/20 0.33
GAA P10253 1/20 0.33
CASP3 P42574 1/20 0.33
SENP7 Q9BQF6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18514539 0.93 AAK1 (0.36) AAK1KMT2AHTTSMN1; SMN2LMNA
SCHEMBL18514537 0.93 SLC22A12 (0.41) AAK1KMT2AHTTSMN1; SMN2LMNA
SCHEMBL18514943 0.93 KMT2A (0.36) AAK1KMT2AHTTSMN1; SMN2LMNA
SCHEMBL18514521 0.92 MRGPRX4 (0.39) KMT2AHTTSMN1; SMN2LMNAMEN1
SCHEMBL18514531 0.92 POLB (0.39) AAK1KMT2AHTTSMN1; SMN2LMNA
SCHEMBL18514529 0.92 RAB9A (0.39) AAK1KMT2AHTTSMN1; SMN2LMNA
SCHEMBL18515403 0.92 FFAR4 (0.40) KMT2AHTTSMN1; SMN2LMNASLC22A12
SCHEMBL18514533 0.92 KMT2A (0.40) AAK1KMT2AHTTSMN1; SMN2LMNA
SCHEMBL18513862 0.91 MAPT (0.41) KMT2ASMN1; SMN2MEN1ALDH1A1NPC1
SCHEMBL18513866 0.91 NPC1 (0.41) HTTSMN1; SMN2LMNAALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9788547-B2 Aromatic compound and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-17 US disclosed
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 US disclosed
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 US disclosed
EP-3130584-A1 AROMATIC COMPOUND AND USES THEREOF Sumitomo Chemical Company Limited (JP) 2017-02-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-0 AAK1 955/4885KMT2A 705/4885HTT 2020/4885
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-10 AAK1 844/4885KMT2A 1447/4885HTT 2506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.